Format

Send to:

Choose Destination
See comment in PubMed Commons below
Schizophr Res. 2011 Nov;132(2-3):121-4. doi: 10.1016/j.schres.2011.08.007. Epub 2011 Sep 3.

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response.

Author information

  • 1Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada.

Abstract

Neurexin-1 (NRXN1) modulates recruitment of NMDA receptors. Furthermore, clozapine reduces hyperactivity of NMDA receptors. Thus, regulation of the NRXN1 gene may mediate the efficacy of clozapine at reducing cortical hyperactivity. We examined the putative functional SNP, rs1045881, for association with schizophrenia, and the potential role of this SNP in clozapine response. The rs1045881 variant was not significantly associated with schizophrenia (N=302 case-control pairs), but with clozapine response (N=163; p=0.030). Baseline and BPRS scores after six months revealed a trend for rs1045881 genotype by treatment interaction (p=0.079). In the post hoc analysis, a significant association between BPRS negative symptoms score and genotype was observed (p=0.033). These results suggest that the rs1045881 NRXN1 polymorphism may influence clozapine response.

Copyright © 2011 Elsevier B.V. All rights reserved.

PMID:
21890328
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk